Search
for
Did you mean Pituitary Hormone?
Sort by
Research 30 of 1000+
- FRI334 A Case Of Delayed Onset Sheehan's Syndrome With Diabetes Insipidus
- Physiology of Testicular Function
- Fundamental Concepts and Novel Aspects of Polycystic Ovarian Syndrome: Expert Consensus Resolutions
- Hormonal therapies for acne
- Hormonal, Medical, and Nonsurgical Aspects of Gender Affirmation
- Hirsutism in the Adolescent Female
- Gender-Affirming Hormone Therapy for Transgender Men
- Oligomenorrhoea in Exercising Women
- Secondary amenorrhea
- Polycystic Ovary Syndrome: A Comprehensive Review of Its Clinical Presentation, Comorbidities, Long-Term Complications and Management
- Polycystic Ovary Syndrome: Update on Diagnosis and Treatment
- Module-based complexity formation: periodic patterning in feathers and hairs
- Acne in the adult female patient: a practical approach
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
- Adult skin acute stress responses to short‐term environmental and internal aggression from exposome factors
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor
- Menopausal Acne – Challenges And Solutions
- Association of estrogen receptor gene variants (ESR1 and ESR2) with polycystic ovary syndrome in Tunisia
- Deslorelin treatment of hyperoestrogenism in neutered ferrets (Mustela putorius furo): a case report
- PCOS: Perspectives from a Pediatric Endocrinologist and a Pediatric Gynecologist
- Telogen Effluvium
- Acne and acneiform eruptions
- Polycystic Ovary Syndrome: A Complex Interplay of Hormones and Metabolism
- Skin aging: mechanisms, evaluation, and rejuvenation
- ACOG Practice Bulletin No. 108: Polycystic Ovary Syndrome
- Androgenetic Alopecia
- Triple Hormonal Blockade (ADT3): A Patient’s Perspective
- Expression of Hypothalamic–Pituitary–Thyroid Axis RelatedGenes in the Human Skin
- Hormonal Treatment of Transgender Women with Oral Estradiol
- New effects of caffeine on corticotropin‐releasing hormone (CRH)‐induced stress along the intrafollicular classical hypothalamic–pituitary–adrenal (HPA) axis (CRH‐R1/2, IP<sub>3</sub>‐R, ACTH, MC‐R2) and the neurogenic non‐HPA axis (substance P, p75<sup>NTR</sup>and TrkA) in<i>ex vivo</i>human male androgenetic scalp hair follicles